+1 (304) 470-2225

Development & Marketing Strategy behind, Daiichi Sankyo’s DS-1062, $6 billion deal with AstraZeneca

Daiichi Sankyo unveiled about the collaboration between them and AstraZeneca for antibody drug conjugate, DS-1062. This news has created absolute havoc in the Pharma market. As per the agreement, AstraZeneca will pay Daiichi Sankyo up […]

Read More

Get In Touch

Let's keep the conversation going